28 results
DEFA14A
INBX
Inhibrx Biosciences, Inc.
23 Jan 24
Additional proxy soliciting materials
6:38am
, for clarity, the research program that generated INBRX-101).
“Accounting Expert” has the meaning set forth in Section 5.8(b).
“Affiliate” has the meaning … to SpinCo and the Company (the “Accounting Expert”) for resolution, together with such supporting documentation and information as the Parties deem
8-K
EX-2.2
INBX
Inhibrx Biosciences, Inc.
23 Jan 24
Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B
6:35am
, the research program that generated INBRX-101).
“Accounting Expert” has the meaning set forth in Section 5.8(b).
“Affiliate” has the meaning set forth … and the Company (the “Accounting Expert”) for resolution, together with such supporting documentation and information as the Parties deem appropriate (it being
DEF 14A
im038
28 Apr 21
Definitive proxy
7:51am
424B4
h3396
19 Aug 20
Prospectus supplement with pricing info
5:21pm
DRS
3bj60p1g555buu fts
26 Jun 20
Draft registration statement
12:00am
DRS
EX-10.1
hbsypnwe3h
26 Jun 20
Draft registration statement
12:00am
S-1
EX-10.1
4h1g5y
3 Jun 19
IPO registration
4:17pm
S-1
EX-10.17
vrvy2ald95yeub3mdb6g
3 Jun 19
IPO registration
4:17pm
S-1
h0gnaycndy 4qfqgnb5
3 Jun 19
IPO registration
4:17pm
S-1
EX-10.16
9f2b089jzed48c8ss
3 Jun 19
IPO registration
4:17pm
S-1
EX-10.11
ks833i0gccrom
3 Jun 19
IPO registration
4:17pm
S-1
EX-10.24
yhbm3xrrp8mbr za
3 Jun 19
IPO registration
4:17pm